Check AD-218 for fibromyalgia symptoms and safety
Part of Heart & circulation, Hormones & metabolism clinical trials.
This phase 3 study tests whether AD-218 works and is safe for people with fibromyalgia. It may help by improving symptoms, but it also carefully monitors side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 19 years old or older
- Sign and date the informed consent form before joining
- Do not have a past diagnosis of fibromyalgia
- Avoid having muscle disease history such as myopathy
- If you have blood tests, CK (a muscle enzyme) should be less than 2 times the upper normal limit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares how the body processes two different forms of the same drug, AD-117 and AD-117A, and checks for safety. It's for healthy adults to help ensure the drug works similarly and safely.
This study tests how two experimental drugs, called AD-236A and AD-236B, interact in the body and checks if they are safe. Healthy volunteers are needed to see how the drugs affect each other.
This trial tests two new drugs, AD-118 and AD-1181, to see if they are safe and how the body handles them. It is for healthy volunteers to gather early information before testing in patients.
This early-stage trial tests how a new drug called AD-230 moves through the body and whether it's safe in healthy volunteers. Researchers will measure drug levels in your blood and watch for any side effects.
This early-stage study tests a new investigational drug called AD-231 to see how safe it is and how your body processes it. Researchers will compare it to a combination of three related drugs to understand which approach works best.
This study tests a new drug called AD-230 to understand how your body absorbs and processes it, and whether food affects this process. You'll be a healthy volunteer helping researchers gather safety information.
Hear when a new Mixed Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.